Related Experiment Videos
Time-Cumulative Residual Cardiovascular Risk in Patients with Coronary Heart Disease and Diabetes: A 10-Year
Zeping Li1, Guangling Li1, Yanan Wang1
1Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, Wuhan 430030, China.
Insights
Patients with coronary heart disease (CHD) and diabetes mellitus (DM) face a growing cardiovascular risk over time. While initial treatment helps, long-term outcomes show significantly elevated risks, necessitating proactive management strategies.
Area of Science:
- Cardiology
- Endocrinology
- Epidemiology
Background:
- Patients with coronary heart disease (CHD) and diabetes mellitus (DM) experience substantial residual cardiovascular risk despite current therapies.
- The long-term progression and temporal pattern of this increased risk are not fully understood.
Purpose of the Study:
- To investigate the long-term cardiovascular risk trajectory in patients with CHD complicated by DM.
- To clarify the temporal pattern of excess risk in this patient population.
Main Methods:
- Retrospective cohort study using UK Biobank and Tongji Hospital data.
- Follow-up for up to 10 years with major adverse cardiovascular events (MACE) as the primary endpoint.
- Propensity score matching and multivariable Cox regression were used to analyze risk.
Main Results:
- Initially, no significant difference in MACE risk was observed between CHD and CHD with DM patients post-matching.
- A progressive divergence in survival curves occurred over time, with significant risk differences emerging at 10 years.
- Diabetes was confirmed as an independent risk factor for long-term MACE in both cohorts.
Conclusions:
- Diabetes significantly elevates long-term residual cardiovascular risk in CHD patients, exhibiting a time-cumulative effect.
- While early risk may be mitigated by current therapies, long-term adverse events remain high.
- Intensified, proactive long-term management strategies are crucial for CHD patients with DM.
Background:
Patients with coronary heart disease (CHD) complicated by diabetes mellitus (DM) remain at substantial residual cardiovascular risk despite contemporary guideline-directed medical therapy. However, the long-term trajectory of this excess risk and its temporal pattern have not been fully clarified.
Methods:
This is a retrospective cohort study based on a large-scale public database and real-world clinical data. The primary cohort was derived from the UK Biobank (UKB), including 7491 CHD patients and 2322 CHD with DM patients; the validation cohort included 362 CHD patients from Tongji Hospital. Both cohorts were followed for up to 10 years, with major adverse cardiovascular events (MACE) as the primary endpoint. Propensity score matching (PSM) was employed to balance baseline confounders. Kaplan-Meier analysis combined with piecewise log-rank tests were used to assess cumulative risk differences at various follow-up time points. Multivariable Cox proportional hazards models were constructed to evaluate the independent impact of diabetes.
Results:
In the UKB cohort, CHD with DM patients exhibited significantly higher risks of MACE and cardiovascular death before matching. After 1:1 PSM, no significant difference in MACE risk was observed during the early follow-up period (1 year, p > 0.05). However, survival curves showed progressive divergence over time, with the risk difference reaching statistical significance at 10 years (p = 0.0004), demonstrating a pronounced time-cumulative effect. The Tongji validation cohort similarly confirmed that event-free survival was significantly lower in the CHD with DM group (p = 0.0028). Independent risk factor analysis using multivariable Cox regression showed that after adjusting for age, sex, smoking, and lipid parameters, diabetes remained an independent risk factor for long-term MACE (UKB cohort HR > 1; Tongji cohort HR = 1.86, 95% CI: 1.20-2.86, p = 0.005).
Conclusions:
Diabetes significantly increases the long-term residual cardiovascular risk in CHD patients. This excess risk is characterized by a clear time-cumulative effect: under modern guideline-directed medical therapy, early risk may be effectively buffered, but long-term adverse events remain markedly elevated. More proactive and intensified long-term intervention strategies are urgently needed for CHD patients with comorbid diabetes.
Related Concept Videos
Diabetic Retinopathy
Diabetic Nephropathy
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Complications of Diabetes Mellitus